Allergy Therapeutics PLC | Income Statement
Fiscal year is July-June. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
39,279.00
41,955.00
43,230.00
48,509.00
64,138.00
68,346
Cost of Goods Sold (COGS) incl. D&A
12,327.00
12,232.00
12,419.00
14,310.00
17,197.00
17,463
Gross Income
26,952.00
29,723.00
30,811.00
34,199.00
46,941.00
50,883
SG&A Expense
25,934.00
28,524.00
29,035.00
45,671.00
53,355.00
57,573
EBIT
-
1,199.00
1,776.00
11,322.00
5,715.00
6,690
Unusual Expense
149.00
13.00
205.00
2,047.00
707.00
788
Non Operating Income/Expense
446.00
173.00
1,028.00
1,147.00
2,348.00
67
Interest Expense
211.00
102.00
27.00
122.00
71.00
122
Pretax Income
529.00
1,008.00
581.00
12,214.00
2,669.00
7,526
Income Tax
104.00
267.00
473.00
858.00
188.00
7
Consolidated Net Income
633.00
741.00
108.00
13,072.00
2,481.00
7,533
Net Income
633.00
741.00
108.00
13,072.00
2,481.00
7,533
Net Income After Extraordinaries
633.00
741.00
108.00
13,072.00
2,481.00
7,533
Net Income Available to Common
633.00
741.00
108.00
13,072.00
2,481.00
7,533
EPS (Basic)
0.00
0.00
0.00
0.02
0.00
0.01
Basic Shares Outstanding
453,017.00
451,542.00
475,197.00
570,344.00
592,192.00
595,099
EPS (Diluted)
0.00
0.00
0.00
0.02
0.00
0.01
Diluted Shares Outstanding
471,652.00
471,507.00
498,242.00
589,229.00
592,192.00
595,099
EBITDA
2,360.00
2,486.00
3,069.00
9,656.00
3,779.00
4,670
Other Operating Expense
-
-
-
150.00
699.00
-
Non-Operating Interest Income
19.00
71.00
65.00
130.00
62.00
141
About Allergy Therapeutics
View Profile
